Return to search

Management of COPD and Comorbidities in COPD patients by Dispensing Pharmaceutical Care following Global Initiative for chronic Obstructive Lung Disease-Guidelines (GOLD guidelines 2020): A study protocol for a Prospective Randomized Clinical Trial

Yes / COPD (chronic obstructive pulmonary disease) is a medical condition that encompasses several
chronic, progressive, and severe respiratory illnesses, such as emphysema and chronic bronchitis.
COPD is the 4th most deadly disease in the world and its prevalence is expected to increase.
Despite the abundance of information on the disease’s etiology, pathophysiology, and treatment
possibilities, it has long been underdiagnosed and underreported for a long time, particularly in
developing countries. The symptoms of COPD result in significant impairments and significant
impact on quality of life. COPD is the third leading cause of death in Pakistan. According to the
published literature, COPD has been found to be associated with a serious economic burden,
either the direct cost to healthcare systems in the form of frequent hospital admissions or indirect
costs to patients suffering from COPD. Despite the availability of excellent medication, COPD
treatment goals are frequently not achieved resulting in poor management of COPD. The recent
studies revealed that due to the missing role of Pharmacists in most of the public sector hospitals
of Pakistan, the COPD disease management protocols are not being properly followed. Pharmacists
can help the healthcare system by implementing these management protocols that focus on
patient education about the disease, prescribed medications, and proper inhalation techniques.
Furthermore, the pharmacists as an effective healthcare’s team member properly educate the
patients about the ongoing assessments and their willingness to follow treatment. / Researchers Supporting Project Number (RSP2023R161), King Saud University, Riyadh, Saudi Arabia. We are also thankful to Higher Education Commission (HEC) Pakistan for providing grant under the National Research Program for Universities- NRPU Ref No. 20–14413/NRPU/R&D/HEC/2021

Identiferoai:union.ndltd.org:BRADFORD/oai:bradscholars.brad.ac.uk:10454/20121
Date23 October 2023
CreatorsKanwal, H., Khan, Shahzeb, Eldesoky, G.E., Mushtaq, S., Khan, A.
Source SetsBradford Scholars
LanguageEnglish
Detected LanguageEnglish
TypeArticle, Published version
Rights© 2023 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)., Unspecified

Page generated in 0.002 seconds